Exploring how induced pluripotent stem cells (iPSCs) and CRISPR technologies are transforming regenerative medicine and disease treatment.
Breakthrough in GMP-compliant iPSC therapy for recessive dystrophic epidermolysis bullosa (RDEB) treatment using genetically reprogrammed skin cells.